Trial intelligence / Profile preview

Changes in Bile Acid Homeostasis After Cholecystectomy

NCT03168555Phase 4Completed

Sponsor
Zealand University Hospital
Start
Jun 2017
Primary completion
May 2019
Countries
1
01

Overview

Phase 4, open-label, single-arm trial, sponsored by Zealand University Hospital. Primary endpoint: Change in Stimulated Fibroblast Growth Factor 19 (FGF19) From Baseline Before Versus Post Cholecystectomy. Started Jun 2017; status: completed.

Beyond the preview

Go deeper on NCT03168555.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03168555.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call